Thermo Fisher CDR (Cad Hedged) (TMO.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,325,000 | 2,399,000 | 2,103,000 | 1,335,000 | 786,200 |
| Receivables | 6,472,000 | 4,952,000 | 4,136,000 | 4,311,000 | 3,426,800 |
| Inventories | 4,029,000 | 3,370,000 | 3,005,000 | 2,971,000 | 2,213,300 |
| Other current assets | 1,131,000 | 1,172,000 | 1,381,000 | 804,000 | 594,700 |
| TOTAL | $21,957,000 | $11,893,000 | $10,625,000 | $9,421,000 | $7,021,000 |
| Non-Current Assets | |||||
| PPE Net | 5,912,000 | 4,749,000 | 4,165,000 | 4,047,000 | 2,577,800 |
| Intangibles | 38,726,000 | 39,728,000 | 40,325,000 | 41,974,000 | 35,296,800 |
| Other Non-Current Assets | 2,457,000 | 2,011,000 | 1,117,000 | 1,227,000 | 1,011,900 |
| TOTAL | $47,095,000 | $46,488,000 | $45,607,000 | $47,248,000 | $38,886,500 |
| Total Assets | $69,052,000 | $58,381,000 | $56,232,000 | $56,669,000 | $45,907,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,628,000 | 676,000 | 1,271,000 | 2,135,000 | 1,255,500 |
| Accounts payable and accrued liabilities | 2,175,000 | 1,920,000 | 1,615,000 | 1,428,000 | 926,200 |
| Accrued Expenses | 4,230,000 | 2,685,000 | 2,452,000 | 2,766,000 | 2,032,800 |
| TOTAL | $10,304,000 | $6,197,000 | $6,147,000 | $7,048,000 | $4,865,800 |
| Non-Current Liabilities | |||||
| Long Term Debt | 19,107,000 | 17,076,000 | 17,719,000 | 18,873,000 | 15,372,400 |
| Deferred Revenues | 1,271,000 | 916,000 | 809,000 | 719,000 | 485,900 |
| Other Non-Current Liabilities | 3,340,000 | 3,241,000 | 2,515,000 | 2,569,000 | 1,572,600 |
| TOTAL | $24,241,000 | $22,509,000 | $22,499,000 | $24,208,000 | $19,502,400 |
| Total Liabilities | $34,545,000 | $28,706,000 | $28,646,000 | $31,256,000 | $24,368,200 |
| Shareholders' Equity | |||||
| Common Shares | 437,000 | 434,000 | 432,000 | 428,000 | 415,100 |
| Retained earnings | 28,116,000 | 22,092,000 | 18,696,000 | 15,914,000 | 13,926,900 |
| Other shareholders' equity | -2,807,000 | -2,679,000 | -2,498,000 | -2,003,000 | -2,636,300 |
| TOTAL | $34,507,000 | $29,675,000 | $27,586,000 | $25,413,000 | $21,539,300 |
| Total Liabilities And Equity | $69,052,000 | $58,381,000 | $56,232,000 | $56,669,000 | $45,907,500 |